Vol 9, Supp. A (2018)

Date published: 2019-06-07

Table of Contents

open access


Nilotinib treatment of a patient with chronic myelogenous leukemia after previous failure to imatinib and dasatinib

Marzena Wątek, Ewa Wasińska, Sylwia Kościołek-Zgódka, Marcin Pasiarski, Stanisław Góźdź

Case report

DOI: 10.5603/Hem.2018.0010


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl